Cansino Biologics Inc (OP: CASBF )

2.300 -0.530 (-18.73%)

Streaming Delayed Price Updated: 9:30 AM EDT, Jun 25, 2024 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	270
Open	2.300
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	2.830
Today's Range	2.300 - 2.300
52wk Range	1.860 - 3.900
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Week In Review: BeiGene And Bristol-Myers Squibb Close BeiGene-Celgene PD-1 Partnership

August 12, 2023

BeiGene and Bristol-Myers Squibb have formally completed the breakup of the BeiGene-Celgene partnership, returning 23.3 million ordinary BeiGene shares to BeiGene. Meanwhile, Gracell Biotechnologies...

Via Talk Markets

Why Is CanSino Biologics (CASBF) Stock Soaring Today?

November 02, 2022

CanSino Biologics shares are ripping higher on Wednesday, with CASBF stock up more than 75%. The move comes as China pushes for more vaccines.

Via InvestorPlace

Performance

YTD	-14.02%	-14.02%
1 Month	N/A	N/A
3 Month	+23.66%	+23.66%
6 Month	-22.30%	-22.30%
1 Year	-27.70%	-27.70%

More News

Week In Review: Fosun Acquires VerImmune Cancer Immunotherapy In $125 Million Deal

May 28, 2022

Via Talk Markets

Week In Review: Shanghai Regor To Discover Metabolic Therapies For Lilly In $1.55 Billion Deal

December 11, 2021

Via Talk Markets

Week In Review: Zai Lab Raises $750 Million In Private Placement For In-Licensed/Novel Drugs

April 24, 2021

Via Talk Markets

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.